Anúncio
Anúncio

ANIX

ANIX logo

Anixa Biosciences, Inc.

3.39
USD
Patrocinado
-0.03
-0.91%
09 de jan., 15:59 UTC -5
Encerrado
exchange

Pós-Mercado

3.47

+0.08
+2.39%

Relatórios de Lucros ANIX

Rácio de surpresa positiva

ANIX separação 20 de 28 últimas estimativas.

71%

Próximo Relatório

Data do Próximo Relatório
09 de mar. de 2026
Estimate for Q1 26 (Revenue/ EPS)
--
/
-$0.10
Mudanças implicadas de Q4 25 (Revenue/ EPS)
--
/
--
Mudanças implicadas de Q1 25 (Revenue/ EPS)
--
/
--

Anixa Biosciences, Inc. earnings per share and revenue

On 08 de jan. de 2026, ANIX reported earnings of -- USD per share (EPS) for Q4 25, -- the estimate of -0.08 USD, resulting in a --% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -1.17% price change (close before vs. close after earnings).
Looking ahead to Q1 26, 5 analistas forecast an EPS of -0.10 USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
FAQ
For Q4 2025, Anixa Biosciences, Inc. reported EPS of --, missing estimates by --, and revenue of --, 0% as expectations.
The stock price moved down -1.17%, changed from $3.42 before the earnings release to $3.38 the day after.
The next earning report is scheduled for 09 de mar. de 2026.
Based on 5 analistas, Anixa Biosciences, Inc. is expected to report EPS of -$0.10 and revenue of -- for Q1 2026.
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio